United States · Funded startup
5 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Viamet Pharmaceuticals and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$91Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Novartis Venture Fund
Intersouth Partners
Hatteras Venture Partners
Astellas Venture Management
Lilly VenturesFrom a historical funding record
Novartis Venture FundIntersouth PartnersHatteras Venture PartnersAstellas Venture Management
Lilly VenturesReported by sec.govSEC filing: $10.0M sold, first sale Jun 2009
Reported by findarticles.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Intersouth PartnersHatteras Venture PartnersNovartis Venture FundAstellas Venture ManagementLilly VenturesLilly VenturesLurie Investment FundNovartis Option FundDepartment Of DefenseMissing a round, or an investor who was in one? Tell us.
Viamet Pharmaceuticals's investors include Intersouth Partners, Hatteras Venture Partners, Novartis Venture Fund, Astellas Venture Management and Lilly Ventures, and 4 more on record.
Viamet Pharmaceuticals has raised $91M across 5 rounds since 2005.
Viamet Pharmaceuticals's most recent round was a Grant of $1.9M in Jun 2015.
Viamet Pharmaceuticals's largest round on record is $60M (Series D), in Oct 2014.
Viamet Pharmaceuticals's first round on record, in Aug 2005, was backed by Intersouth Partners.
Viamet Pharmaceuticals's latest named round is a Grant, in Jun 2015.
Viamet Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·